• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. GlaxoSmithKline Files Drug Application for UMEC in US

    GlaxoSmithKline Files Drug Application for UMEC in US

  2. OFT Alleges GlaxoSmithKline Concluded Pacts Which Infringed Competition Law

    OFT Alleges GlaxoSmithKline Concluded Pacts Which Infringed Competition Law

  3. GlaxoSmithKline PLC GSK Q3 2010 Earnings Call Transcript

    Thank you, very much and thank you all for joining us on this Q3 call of GSK . I am going to take you through just some headlines on the overall performance of the Company and RnD and then Julian Heslop, our CFO will take you through some more detail before we open up for questions.

  4. GlaxoSmithKline PLC GSK Q1 2011 Earnings Call Transcript

    My name is Simon, I'm your operator today. The format of the call will be some opening remarks from Andrew and Simon and (technical difficulty)

  5. Avoid Medicare Advantage Plans

    GlaxoSmithKline GSK reported solid second-quarter results on Wednesday that were largely in line with our expectations, and we don't anticipate any changes to our fair value estimate. Sales increased 10% from the prior year driven by strong sales of asthma medicine Advair, diabetes medicine ...

  6. Research and Markets: Analyzing the Chemical Industry in the UK 2013

    Research and Markets: Analyzing the Chemical Industry in the UK 2013

  7. Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement

    Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement

  8. Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact

    Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact

  9. Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement

    Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement

  10. Cure Duchenne Hosts Drisapersen Update Webinar With GSK on May 6, 2013

    Cure Duchenne Hosts Drisapersen Update Webinar With GSK on May 6, 2013

12345
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.